Market Capitalization (Millions $) |
1,629 |
Shares
Outstanding (Millions) |
56 |
Employees |
- |
Revenues (TTM) (Millions $) |
27 |
Net Income (TTM) (Millions $) |
-352 |
Cash Flow (TTM) (Millions $) |
-51 |
Capital Exp. (TTM) (Millions $) |
1 |
Agios Pharmaceuticals Inc
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the development of therapies for cancer and rare genetic diseases. The company utilizes its expertise in cellular metabolism to discover and develop potential treatments. Agios is known for its innovative approaches to targeting specific metabolic pathways that play a critical role in disease progression. The company's pipeline includes both small molecule and antibody-based therapies, with several candidates in various stages of clinical development. Agios Pharmaceuticals aims to deliver breakthrough treatments that can significantly improve the lives of patients in need.
Company Address: 88 Sidney Street Cambridge 2139 MA
Company Phone Number: 649-8600 Stock Exchange / Ticker: NASDAQ AGIO
|